ACB Logo

Aurora Cannabis Inc (ACB) Stock Forecast & Price Prediction

Live ACB Stock Price & Analysis

Home โ€บ Stocks โ€บ Canada | NASDAQ | Healthcare | Drug Manufacturers - Specialty & Generic

$6.03

-0.22 (-3.52%)

12 Month Price Forecast For ACB

$6.03
Current Price
$331.03M
Market Cap
6 Ratings
Buy 3
Hold 3
Sell 0
Wall St Analyst Ratings

Distance to ACB Price Forecasts

N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A

ACB Price Momentum

+74.3%
1 Week Change
+46.0%
1 Month Change
+38.9%
1 Year Change
+41.9%
Year-to-Date Change
-35.5%
From 52W High of $9.35
+112.3%
From 52W Low of $2.84

๐Ÿค” Considering Aurora Cannabis (ACB)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 10, 2025 1:38 PM UTC

ACB Analyst Ratings & Price Targets

Based on our analysis of 7 Wall Street analysts, ACB has a consensus that is neutral. The median price target is $0.00, with forecasts ranging from $0.00 to $0.00. Currently, there are 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings.

With ACB currently trading at $6.03, the median price forecast suggests a -100.0% downside. The most optimistic forecast comes from Pablo Zuanic at Zuanic & Associates, projecting a -100.0% downside, while Pablo Zuanic at Zuanic & Associates provides the most conservative target, suggesting a -100.0% downside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

ACB Analyst Consensus

3
Buy
3
Hold
0
Sell

ACB Price Target Range

Low
N/A
Average
N/A
High
N/A
Current: $6.03

Latest ACB Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for ACB.

Date Firm Analyst Rating Change Price Target
Jun 27, 2024 Zuanic & Associates Pablo Zuanic Neutral Initiates $0.00
Jun 16, 2023 CIBC John Zamparo Neutral Maintains $1.00
Jun 15, 2023 Canaccord Genuity Matt Bottomley Hold Maintains $0.80
Feb 13, 2023 CIBC John Zamparo Neutral Maintains $1.75
Sep 21, 2022 Piper Sandler Michael Lavery Neutral Maintains $3.00
Sep 28, 2021 MKM Partners Bill Kirk Neutral Upgrade $0.00
Dec 18, 2020 BMO Capital Tamy Chen Underperform Downgrade $9.00
Nov 25, 2020 Cowen & Co. Outperform Initiates $0.00
Nov 25, 2020 Bank of America Neutral Downgrade $0.00
Nov 25, 2020 B of A Securities Neutral Downgrade $0.00
Nov 25, 2020 Stifel Sell Downgrade $0.00
Nov 25, 2020 Needham Hold Initiates $0.00
Nov 25, 2020 Piper Sandler Neutral Maintains $0.00
Nov 25, 2020 Jefferies Buy Initiates $0.00
Nov 25, 2020 Stifel Nicolaus Hold Initiates $0.00
Nov 25, 2020 MKM Partners Sell Initiates $0.00
Nov 25, 2020 Seaport Global Neutral Initiates $0.00
Nov 25, 2020 Piper Jaffray Neutral Maintains $0.00
Nov 25, 2020 Ladenburg Thalmann Neutral Downgrade $0.00
Nov 25, 2020 Desjardins Buy Initiates $0.00

Stocks Similar to Aurora Cannabis Inc

The following stocks are similar to Aurora Cannabis based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Aurora Cannabis Inc (ACB) Financial Data

Aurora Cannabis Inc has a market capitalization of $331.03M with a P/E ratio of 31.7x. The company generates $207.14M in trailing twelve-month revenue with a -14.7% profit margin.

Revenue growth is +28.5% quarter-over-quarter, while maintaining an operating margin of -1.7% and return on equity of -5.8%.

Valuation Metrics

Market Cap $331.03M
Enterprise Value $140.39B
P/E Ratio 31.7x
PEG Ratio -54.8x
Price/Sales 1.1x

Growth & Margins

Revenue Growth (YoY) +28.5%
Gross Margin +89.6%
Operating Margin -1.7%
Net Margin -14.7%
EPS Growth +36.9%

Financial Health

Cash/Price Ratio +0.0%
Current Ratio 3.8x
Debt/Equity 17.3x
ROE -5.8%
ROA -1.2%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Aurora Cannabis Inc logo

Aurora Cannabis Inc (ACB) Company Overview

About Aurora Cannabis Inc

What They Do

Produces and sells cannabis and related products.

Business Model

Aurora Cannabis Inc. generates revenue through the cultivation, distribution, and sale of a wide range of cannabis and cannabis-derived products, targeting both medical and recreational markets. The company operates two main segments: Canadian Cannabis, which focuses on the domestic market, and Plant Propagation, supplying vegetables and ornamental plants. Aurora also offers patient support services and has a diverse portfolio of brands catering to various consumer preferences.

Additional Information

Founded in 2013 and headquartered in Edmonton, Canada, Aurora Cannabis has a significant presence in both the Canadian and international cannabis markets. Its extensive product offerings include dried cannabis, oils, capsules, edibles, and CBD products, appealing to a broad customer base. The company continues to expand its brand portfolio and enhance its market reach.

Company Information

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1,073

CEO

Mr. Miguel Martin

Country

Canada

IPO Year

2014

Aurora Cannabis Inc (ACB) Latest News & Analysis

ACB stock latest news image
Quick Summary

Aurora Cannabis reported record Q3/FY2025 results with high sales, margins, and free cash flow. Cash equivalents rose to $180.2 million, and the company remains debt-free amid strong European sales growth.

Why It Matters

Aurora Cannabis' record Q3 results and strong cash position indicate robust financial health, driving confidence in growth and stability, especially in the expanding European market.

Source: Seeking Alpha
Market Sentiment: Positive
ACB stock latest news image
Quick Summary

Aurora Cannabis Inc (ACB) reported Q3 fiscal 2025 net revenue of CA$88.2 million, up from CA$64.4 million in the same quarter last year.

Why It Matters

Aurora Cannabis's revenue growth signals strong demand and operational improvements, potentially boosting investor confidence and stock performance in the cannabis sector.

Source: Benzinga
Market Sentiment: Positive
ACB stock latest news image
Quick Summary

Aurora Cannabis Inc. will hold its Q3 2025 earnings conference call on February 5, 2025, at 8:00 AM ET, featuring key executives and analysts from various financial institutions.

Why It Matters

Aurora Cannabis's Q3 2025 earnings call will provide key insights into its financial performance and strategic direction, impacting stock valuations and investor sentiment.

Source: Seeking Alpha
Market Sentiment: Neutral
ACB stock latest news image
Quick Summary

Aurora Cannabis (NASDAQ: ACB) reported Q3 fiscal 2025 net revenue of $88.2M, up 37% YoY, with net income of $31.2M, up 282% YoY. Free cash flow reached $27.4M, maintaining a debt-free status.

Why It Matters

Aurora Cannabis' strong revenue growth, record net income, and positive cash flow signal robust operational performance, enhancing investor confidence and potential for future growth.

Source: PRNewsWire
Market Sentiment: Neutral
ACB stock latest news image
Quick Summary

Aurora Cannabis Inc. (NASDAQ: ACB, TSX: ACB) has entered a strategic supply agreement with SNDL Inc. for premium cannabis flower from SNDL's New Brunswick facility.

Why It Matters

The supply agreement between Aurora Cannabis and SNDL enhances Aurora's product offerings and strengthens its supply chain, potentially boosting revenue and market position in the competitive cannabis sector.

Source: PRNewsWire
Market Sentiment: Neutral
ACB stock latest news image
Quick Summary

Aurora Cannabis Inc. (ACB) reported quarterly earnings of $0.06 per share, exceeding estimates of $0.04 and improving from a loss of $0.20 per share last year.

Why It Matters

Aurora Cannabis' earnings beat estimates and show a significant turnaround from last year's loss, indicating improved financial health and potential for future growth.

Source: Zacks Investment Research
Market Sentiment: Positive

Frequently Asked Questions About ACB Stock

What is Aurora Cannabis Inc's (ACB) stock forecast for 2025?

Analyst forecasts for Aurora Cannabis Inc (ACB) are not currently available. The stock is trading at $6.03.

Is ACB stock a good investment in 2025?

According to current analyst ratings, ACB has 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $6.03. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for ACB stock?

Price predictions from Wall Street analysts for ACB are not currently available. The stock is trading at $6.03.

What is Aurora Cannabis Inc's business model?

Aurora Cannabis Inc. generates revenue through the cultivation, distribution, and sale of a wide range of cannabis and cannabis-derived products, targeting both medical and recreational markets. The company operates two main segments: Canadian Cannabis, which focuses on the domestic market, and Plant Propagation, supplying vegetables and ornamental plants. Aurora also offers patient support services and has a diverse portfolio of brands catering to various consumer preferences.

What is the highest forecasted price for ACB Aurora Cannabis Inc?

Price targets from Wall Street analysts for ACB are not currently available. The stock is trading at $6.03.

What is the lowest forecasted price for ACB Aurora Cannabis Inc?

Price targets from Wall Street analysts for ACB are not currently available. The stock is trading at $6.03.

What is the overall ACB consensus from analysts for Aurora Cannabis Inc?

The overall analyst consensus for ACB is neutral. Out of 7 Wall Street analysts, 3 rate it as Buy, 3 as Hold, and 0 as Sell.

How accurate are ACB stock price projections?

Stock price projections, including those for Aurora Cannabis Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.